Chronic hepatitis C infection–induced liver fibrogenesis is associated with M2 macrophage activation
Bility, Moses T.
McGivern, David R.
Lemon, Stanley M.
Feeney, Eoin R.
MetadataShow full item record
CitationBility, Moses T., Kouki Nio, Feng Li, David R. McGivern, Stanley M. Lemon, Eoin R. Feeney, Raymond T. Chung, and Lishan Su. 2016. “Chronic hepatitis C infection–induced liver fibrogenesis is associated with M2 macrophage activation.” Scientific Reports 6 (1): 39520. doi:10.1038/srep39520. http://dx.doi.org/10.1038/srep39520.
AbstractThe immuno-pathogenic mechanisms of chronic hepatitis C virus (HCV) infection remain to be elucidated and pose a major hurdle in treating or preventing chronic HCV-induced advanced liver diseases such as cirrhosis. Macrophages are a major component of the inflammatory milieu in chronic HCV–induced liver disease, and are generally derived from circulating inflammatory monocytes; however very little is known about their role in liver diseases. To investigate the activation and role of macrophages in chronic HCV–induced liver fibrosis, we utilized a recently developed humanized mouse model with autologous human immune and liver cells, human liver and blood samples and cell culture models of monocyte/macrophage and/or hepatic stellate cell activation. We showed that M2 macrophage activation was associated with liver fibrosis during chronic HCV infection in the livers of both humanized mice and patients, and direct-acting antiviral therapy attenuated M2 macrophage activation and associated liver fibrosis. We demonstrated that supernatant from HCV-infected liver cells activated human monocytes/macrophages with M2-like phenotypes. Importantly, HCV-activated monocytes/macrophages promoted hepatic stellate cell activation. These results suggest a critical role for M2 macrophage induction in chronic HCV-associated immune dysregulation and liver fibrosis.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:29738991
- HMS Scholarly Articles